The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II propensity-matched controlled trial evaluating metformin as an adjunct to neo-adjuvant, concomitant, and adjuvant temozolomide and hypofractionated-accelerated radiotherapy (M-HART) in glioblastoma patients (NCT02780024).
 
George Shenouda
No Relationships to Disclose
 
Roberto Diaz
No Relationships to Disclose
 
Bassam Abdulkarim
No Relationships to Disclose
 
Kevin Petrecca
No Relationships to Disclose
 
Scott Owen
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Novocure; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; Roche Canada; Takeda
 
Valerie Panet-Raymond
No Relationships to Disclose
 
Amro Mohammad
No Relationships to Disclose
 
Miguel Barrera
No Relationships to Disclose
 
William Davalan
No Relationships to Disclose
 
Antoneta Baciu
No Relationships to Disclose
 
Tationa Carvalho
No Relationships to Disclose
 
Melissa Charbonneau
No Relationships to Disclose
 
Marianna Perna
No Relationships to Disclose
 
Tanya Kozel
No Relationships to Disclose
 
Jeffery Hall
No Relationships to Disclose
 
Marie-christine Guiot
No Relationships to Disclose
 
Luis Souhami
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Abbvie
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems